Cutaneous T cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that develops in the T cells. Mycosis fungoides (MF) and Sézary syndrome (SS) are two types of CTCL that mainly present in the skin. However, MF and SS can also be found in the lymph nodes, viscera, and blood. Consequently, the assessment of other white blood cells in the blood, namely CD4+/CD7-, or CD4+/CD26, is important to accurately stage these syndromes. This article reflects on the presentations that took place at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Group 2021 Congress and discusses the role of blood involvement and treatment options in CTCL.
EMJ Hematology 9 [Supplement 7] . 2021
December 2021
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given